Investment Rating - The report maintains an "Overweight" rating for the retail industry [1] Core Insights - The government work report emphasizes the construction of a strong domestic market as a primary task for 2026, proposing various measures to boost consumption, including a 250 billion yuan special bond to support the replacement of consumer goods and a 100 billion yuan fund to promote domestic demand [3][8] - The report highlights the need to optimize service consumption supply and release demand through financial tools, investment in new consumption scenarios, and the removal of unreasonable restrictions in the consumption sector [3][9] - There is a strong focus on supporting new consumption and modern service industries through reforms in the ChiNext board, which may accelerate the asset securitization of key consumption companies and attract new capital [3][9] Summary by Sections Industry Outlook - The report outlines the government's commitment to enhancing consumption through various initiatives, including increasing urban and rural residents' income, expanding personal consumption loans, and promoting service consumption [3][8] - It also mentions the development of event economies and outdoor sports to stimulate consumption and the potential reform of consumption tax to enhance price advantages for tax-exempt channels [3][8] Market Review - For the week of March 2 to March 6, the retail index decreased by 3.91%, while the overall market indices also showed declines, with the Shanghai Composite Index down by 0.93% [10] - Year-to-date performance shows the retail index down by 6.82%, contrasting with positive performances in other sectors like social services and the Shenzhen Composite Index [10][14] Company Valuation Table - The report includes a detailed valuation table for various companies in the retail sector, indicating their market capitalization, closing prices, and projected earnings for 2024 to 2026, along with investment ratings such as "Buy" and "Hold" [17][19] - Notable companies include Pop Mart with a market cap of 2,455 million yuan and a "Buy" rating, and Miniso with a market cap of 372 million yuan also rated as "Buy" [17][19]

Investment Rating - The report maintains an "Accumulate" rating for the power equipment industry [1] Core Views - The power equipment industry is experiencing high demand due to electricity shortages and a continuous positive outlook for energy storage [1] - The report highlights significant growth in energy storage projects, particularly in regions like Inner Mongolia, with nearly 100GWh of projects underway [3] - The report emphasizes the increasing utilization of new energy storage technologies and the supportive policies from the government, which are expected to drive growth in the sector [3] Industry Trends - The energy storage sector is projected to see over 60% growth in installed capacity in 2026, with a compound annual growth rate of 30-50% from 2027 to 2029 [3] - The report notes that the domestic electric vehicle market is expected to stabilize, with a projected 5% growth in 2026 and a significant increase in exports [3] - The report indicates that the demand for lithium batteries remains strong, with prices for lithium carbonate and other materials showing fluctuations [3] Company Performance - Major companies in the sector are showing strong revenue growth, with Daikin Heavy Industries reporting a 63.34% increase in revenue year-on-year [3] - Companies like Ningde Times and BYD are highlighted as leaders in the battery and energy storage markets, with significant investments and expansions planned [3] - The report mentions various companies' strategic partnerships and projects, such as Ningde Times' collaboration with global mining giants and the expansion of production capacities [3] Investment Strategy - The report recommends focusing on leading companies in the energy storage and lithium battery sectors, such as Ningde Times, BYD, and others, due to their strong growth potential and market leadership [3] - It suggests that the energy storage market will continue to grow, driven by both domestic and international demand, particularly in the U.S. and Europe [3] - The report also highlights the importance of technological advancements in energy storage and battery production, which are expected to enhance profitability for key players in the industry [3]

Investment Rating - The report maintains an "Overweight" rating for the retail industry [1] Core Insights - The government work report emphasizes the construction of a strong domestic market as a primary task for 2026, proposing various measures to boost consumption, including a 250 billion yuan special bond to support the replacement of consumer goods and a 100 billion yuan fund to promote domestic demand [3][8] - The report highlights the optimization of service consumption supply and the release of demand through financial tools, urban and rural income increases, and improved vacation systems for students and workers [3][9] - There is a strong focus on supporting new consumption and modern service industries through reforms in the ChiNext board, aiming to attract quality innovative enterprises for IPOs [3][9] - Investment suggestions include focusing on quality supply and reform-related stocks, particularly in service consumption and new consumption sectors [3][9] Summary by Sections Weekly Industry Insights - The report discusses the government's initiatives to enhance consumption, including urban and rural income plans, special bonds, and financial support for consumer loans [3][8] - It also mentions the importance of optimizing service consumption supply and developing new consumption scenarios to stimulate demand [3][8] Weekly Market Review - From March 2 to March 6, the retail index decreased by 3.91%, while the overall market indices showed varied performance, with the Shanghai Composite Index down by 0.93% [10] - Year-to-date, the retail index has declined by 6.82%, contrasting with positive performances in other sectors [10] Company Valuation Table - The report includes a detailed valuation table for various companies, indicating their market capitalization, closing prices, and projected earnings for 2024 to 2026, along with investment ratings [17][18]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company is positioned to benefit from the global supercycle in the power equipment sector, with strong management and operational capabilities driving growth [8][49] - The company has achieved significant revenue and profit growth, with a projected revenue of 21.21 billion yuan and a net profit of 3.16 billion yuan for 2025, reflecting year-on-year increases of 37% and 54% respectively [18] - The company is expanding its overseas business, with expectations of substantial order growth, particularly in North America and Europe, contributing to a robust revenue outlook [8][32] Summary by Sections 1. Company Overview - The company has evolved from a single product focus to a comprehensive range of power equipment, including high-voltage switches, transformers, and energy storage solutions, while also expanding into overseas markets [14][15] 2. Market Dynamics - The global power grid is entering a supercycle driven by increased demand for electricity and the need for infrastructure upgrades, particularly in the context of AI and renewable energy integration [49][52] - The company is well-positioned to capture market share in both domestic and international markets, with a focus on high-margin products and services [8][32] 3. Financial Performance - The company has demonstrated strong financial performance, with a compound annual growth rate (CAGR) of 22% in revenue and 34% in net profit from 2019 to 2025 [18] - The projected earnings per share (EPS) for 2025 is 4.05 yuan, with a price-to-earnings (P/E) ratio of 57.67 based on current valuations [1] 4. Growth Drivers - The company is expected to benefit from a significant increase in overseas orders, with projections of over 10 billion yuan in new orders for 2025, driven by expansion in North America and Europe [32][35] - New product lines, including energy storage and supercapacitors, are anticipated to become key growth areas, complementing the existing product portfolio [15][18] 5. Management and Strategy - The company's management team has a strong technical background and a stable ownership structure, which supports long-term strategic goals [42] - The company has implemented effective incentive mechanisms to align management performance with shareholder interests, contributing to its operational success [46]

Economic Outlook - The surge in oil prices has rapidly increased U.S. inflation expectations, alongside disappointing February non-farm employment data, raising concerns about stagflation and recession in the U.S. market[1] - The overall economic data in the U.S. has been better than expected year-to-date, with a forecast of steady growth in Q1 due to fiscal and monetary stimulus[1] Inflation Projections - The upcoming February CPI is expected to show a month-on-month increase of 0.25-0.3%, with core CPI around 0.2%, indicating continued improvement in inflation pressure[1] - If oil prices remain at $150 per barrel in March and April, the year-on-year CPI growth could increase by 1.80 and 2.04 percentage points, respectively, leading to a CPI of 4.19% and 4.43%[1] Market Reactions - The geopolitical tensions in the Middle East have led to a significant rise in oil prices, with WTI crude increasing by 35.63% during the week, while global stock markets generally declined[2] - The Korean stock market, heavily reliant on imported oil, fell by 10.56% due to these tensions and rising oil prices[2] Risk Factors - Potential risks include unexpected developments in the Iranian situation, excessive rate cuts by the Federal Reserve leading to inflation rebound, and prolonged high interest rates causing liquidity crises in the financial system[1][22]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Insights - The company has issued a profit warning for 2025, expecting revenue between 25.20 billion and 25.50 billion RMB, representing a year-on-year growth of 2.8% to 4.0%. The net profit is projected to be between 1.50 billion and 1.65 billion RMB, indicating a year-on-year increase of 52.7% to 68.0% [7] - The company's operational efficiency has improved due to optimizations in product offerings, store operations, and employee incentives. The establishment of a channel division is expected to drive growth [7] - The company is focusing on store openings and refined operations, including enhanced employee incentives and targeted marketing strategies aimed at younger demographics [7] - The company is elevating its distribution channels to a strategic level, with plans to develop exclusive SKUs for various retail formats, including e-commerce [7] - The company is actively exploring overseas markets, with products already launched in 10 countries, and is progressing towards establishing localized supply chains [7] Financial Summary - Total revenue forecast for 2023 is 2,750 million RMB, with a projected decline of 10.88% in 2024, followed by a recovery in 2025 with a growth of 3.67% [1] - The net profit for 2023 is estimated at 115.58 million RMB, with a significant increase of 357.13% expected in 2024, followed by continued growth in subsequent years [1] - The earnings per share (EPS) is projected to rise from 0.05 RMB in 2023 to 0.11 RMB by 2027 [1] - The price-to-earnings (P/E) ratio is expected to decrease from 24.01 in 2023 to 11.70 by 2027, indicating improved valuation over time [1]

Investment Rating - The report maintains an "Overweight" rating for the pharmaceutical and biotechnology industry [1]. Core Insights - The National People's Congress has designated innovative drugs as a "new emerging pillar industry," indicating a strategic shift for the biopharmaceutical sector from a nurturing phase to a key driver of economic growth [16][17]. - As of March 6, 2026, the total contract value for Chinese innovative drug outbound business development (BD) has reached USD 56.8 billion, with an upfront payment of USD 3.3 billion, representing 41% of the total for 2025 and exceeding the total for 2024 [17][21]. - Despite significant stock price corrections from 2025 highs, the fundamental outlook for quality companies remains strong, with ongoing clinical development and internationalization efforts [21]. Summary by Sections Industry Trends - The A-share pharmaceutical index has seen a year-to-date decline of 2.42%, underperforming the CSI 300 by 1.02% [9]. - The Hang Seng Healthcare Index has outperformed the Hang Seng Technology Index by 0.97% year-to-date [9]. R&D Progress and Company Dynamics - Recent approvals include HSK31679 for non-alcoholic fatty liver disease and the GLP-1 receptor agonist Enogratide, marking significant advancements in innovative drug development [17]. - The report highlights specific companies to watch, including: - PD1 PLUS: Sangamo Therapeutics, CanSino Biologics, Innovent Biologics, and Zai Lab [12]. - ADC: I-Mab Biopharma, Kelun-Biotech, and Baillie Gifford [12]. - Small nucleic acids: Frontier Biotechnologies, Fuyuan Pharmaceutical, and Yuyuan Pharmaceutical [12]. Market Performance - The report notes that the pharmaceutical index's price-to-earnings ratio is currently at 36.18, which is 2.24 times lower than the historical average [9]. - The report identifies high-performing stocks such as Yahu Pharmaceutical (+40.65%) and Duoyi Pharmaceutical (+30.81%) for the week, while stocks like Haixiang Pharmaceutical (-15.06%) and Furu Medical (-13.07%) faced significant declines [9].

Investment Rating - The report maintains an "Overweight" rating for the pharmaceutical and biotechnology industry [1]. Core Insights - The National People's Congress has designated innovative drugs as a "new emerging pillar industry," indicating a strategic shift for the biopharmaceutical sector from a nurturing phase to a core engine of economic growth [16][17]. - As of March 6, 2026, the total value of business development (BD) contracts for Chinese innovative drugs has reached $56.8 billion, with an upfront payment of $3.3 billion, representing 41% of the total for 2025 and exceeding the total for 2024 [17][21]. - Despite significant stock price corrections from 2025 highs, the fundamentals of quality companies remain solid, and the long-term growth logic for innovative drug exports is still intact [21]. Summary by Sections Industry Trends - The A-share pharmaceutical index has seen a year-to-date decline of 2.42%, underperforming the CSI 300 by 1.02% [9]. - The Hang Seng Healthcare Index has outperformed the Hang Seng Technology Index by 0.97% year-to-date [9]. R&D Progress and Company Dynamics - Recent approvals include HSK31679 for non-alcoholic fatty liver disease and the GLP-1 receptor agonist Enogratide, marking significant advancements in innovative drug development [17]. - The report highlights specific companies to watch, including: - PD1 PLUS: Sangamo Therapeutics, CanSino Biologics, Innovent Biologics, and Zai Lab [12]. - ADC: I-Mab Biopharma, Kelun-Biotech, and Baiyue Tianheng [12]. - Small nucleic acids: Frontier Biotechnologies, Fuyuan Pharmaceutical, and Yuyuan Pharmaceutical [12]. Market Performance - The report notes that the pharmaceutical index's price-to-earnings ratio is currently at 36.18, which is 2.24 times lower than the historical average [9]. - The report identifies top-performing stocks for the week, including Yahu Pharmaceutical (+40.65%) and Duoyi Pharmaceutical (+30.81%), while highlighting significant declines in stocks like Haixiang Pharmaceutical (-15.06%) and Furu Medical (-13.07%) [9].

1. Report Industry Investment Rating There is no information provided in the report regarding the industry investment rating. 2. Core Viewpoints of the Report - This week, the bond market showed no obvious trend. The government work report met market expectations, and the hedging sentiment and inflation - rising expectations brought by the US - Iran conflict counteracted each other, keeping bond yields stable. It is expected that the 10 - year Treasury bond yield will remain around 1.8% until there is a clear signal of price recovery [1][13]. - The strong performance of the US economic data, including the significant rebound of the February ISM manufacturing PMI and the decline in the January unemployment rate, challenges the market's expectation of a sharp economic slowdown. The market's expectation of the Fed's short - term interest rate cut remains cautious, and US Treasury yields may face upward pressure [14][17]. 3. Summary by Relevant Catalogs 3.1 One - Week Viewpoint 3.1.1 Analysis of the Trend of Treasury Bond Yields - From February 28th to March 6th, the yield of the 10 - year Treasury bond active bond 250016 decreased by 0.2bp from 1.79% to 1.788%. During the week, the yield fluctuated slightly due to factors such as market sentiment, overseas events, and policy announcements [1][9]. 3.1.2 Impact of the Government Work Report - The quantitative indicators in the government work report, such as the GDP growth target of 4.5% - 5% and the CPI increase target of 2% in 2026, met market expectations. The deficit rate of 4% and local government bonds of 4.4 trillion yuan remained the same as in 2025, with an additional 300 billion yuan of policy - based financial instruments deployed earlier. The monetary policy continued the moderately loose tone, hinting at "precision drip - irrigation" [13]. 3.1.3 Impact of the US Economic Data - The US February ISM manufacturing PMI rebounded significantly to 52.6, much higher than the expected 48.5, indicating the acceleration of manufacturing expansion. The January unemployment rate decreased to 4.3%, and non - farm employment increased moderately, showing a stable labor market. This data combination weakens the market's urgency for the Fed to cut interest rates in the short term, and US Treasury yields may face upward pressure [14][17]. 3.2 Domestic and Overseas Data Summary 3.2.1 Liquidity Tracking - In the open - market operations from March 2nd to March 6th, 2026, the total net investment was - 136.34 billion yuan. The money market interest rates showed certain fluctuations, and the issuance and yield changes of interest - rate bonds were also presented [28][30]. 3.2.2 Domestic and Overseas Macroeconomic Data Tracking - Steel prices showed mixed trends, and LME non - ferrous metal futures official prices generally declined. The prices of commodities such as coal, oil, and vegetables also had corresponding changes, and the prices of US Treasury bonds and some international financial products showed different trends [46][64]. 3.3 One - Week Review of Local Government Bonds 3.3.1 Primary Market Issuance Overview - In the primary market from March 2nd to March 6th, 2026, 30 local government bonds were issued, with a total issuance amount of 272.484 billion yuan, a repayment amount of 17.261 billion yuan, and a net financing amount of 255.224 billion yuan. Six provinces and cities issued local government bonds, and three provinces and cities issued local special refinancing special bonds for replacing hidden debts [74][83]. 3.3.2 Secondary Market Overview - The stock of local government bonds this week was 56.63 trillion yuan, with a trading volume of 62.328 billion yuan and a turnover rate of 1.10%. The top three provinces with active local government bond trading were Guangdong, Hunan, and Jiangsu, and the top three active trading terms were 30Y, 10Y, and 20Y [94]. 3.3.3 Local Government Bond Issuance Plan for This Month - The report presents the local government bond issuance plan for this month, including the planned issuance amounts of different provinces and cities on different dates [99]. 3.4 One - Week Review of the Credit Bond Market 3.4.1 Primary Market Issuance Overview - In the primary market this week, 338 credit bonds were issued, with a total issuance amount of 270.632 billion yuan, a total repayment amount of 173.435 billion yuan, and a net financing amount of 97.196 billion yuan. The net financing amount increased by 187.285 billion yuan compared with last week. Among them, the net financing amount of urban investment bonds was 24.248 billion yuan, and that of industrial bonds was 72.949 billion yuan [101]. 3.4.2 Issuance Interest Rates - The actual issuance interest rates of various bond types this week showed different changes. For example, the issuance interest rate of short - term financing increased by 8.36bp, and that of medium - term notes increased by 31.82bp [113]. 3.4.3 Secondary Market Transaction Overview - The trading volume of credit bonds in the secondary market this week was 603.531 billion yuan. The trading volume of different bond types and ratings varied, and the yields of various bonds showed a general downward trend [115]. 3.4.4 Credit Spreads - The credit spreads of short - term financing and medium - term notes showed a differentiated trend, while the credit spreads of enterprise bonds generally declined, and the credit spreads of urban investment bonds also showed a differentiated trend [122][127][132]. 3.4.5 Grade Spreads - The grade spreads of short - term financing and medium - term notes showed a differentiated trend, the grade spreads of enterprise bonds decreased overall, and the grade spreads of urban investment bonds showed a differentiated trend [137][140][144]. 3.4.6 Trading Activity - The report lists the top five most actively traded bonds of each bond type this week, and the industrial sector had the largest weekly trading volume of bonds [146][147]. 3.4.7 Issuer's Credit Rating Changes - The issuer of Kunming Urban Construction Investment and Development Co., Ltd. had its credit rating raised from AA to AA+ by United Credit Rating Co., Ltd. on March 6, 2026, with a stable outlook [152].

Investment Rating - The report maintains an "Overweight" rating for the gas industry, specifically highlighting companies such as Shouhua Gas, New Oriental Energy, and Jiufeng Energy as key investment opportunities [1]. Core Insights - The report emphasizes the impact of geopolitical conflicts and rising temperatures on gas prices, noting a decrease in US gas prices while European and Chinese gas prices have surged significantly [6][11]. - It highlights the importance of resource value and cost advantages in long-term contracts for companies like Shouhua Gas and New Oriental Energy [6][28]. - The report suggests that the ongoing geopolitical tensions are driving up LNG prices, which in turn affects domestic gas prices [28]. Price Tracking - As of March 6, 2026, US HH gas prices decreased by 3.5%, while European TTF prices increased by 56.3%, and Chinese LNG prices rose by 20.5% [11][12]. - The report indicates that the European gas supply has decreased by 16.2% week-on-week, leading to a significant increase in gas prices [17][28]. Supply and Demand Analysis - The report notes a 7.2% year-on-year increase in US gas storage levels, despite a week-on-week decrease of 1,320 billion cubic feet [15]. - European gas consumption for the period from January to November 2025 was 396.4 billion cubic meters, reflecting a 3.5% year-on-year increase [17]. - The report also mentions that domestic gas consumption in China increased by 2.3% year-on-year, reaching 433.2 billion cubic meters [28]. Pricing Progress - The report states that 68% of cities in China have implemented residential gas price adjustments, with an average increase of 0.22 yuan per cubic meter [41]. - It predicts that the pricing adjustments will continue, with a potential for further recovery in profit margins for city gas companies [41]. Investment Recommendations - The report recommends focusing on companies with resource advantages and long-term contracts, particularly Shouhua Gas, New Oriental Energy, and Jiufeng Energy [6][28]. - It suggests that the ongoing geopolitical tensions highlight the importance of energy independence and the need for companies with gas production capabilities [28].